Agent 2 preferentially concentrates in TrkC-positive cells exhibiting increased photocytotoxicity, as demonstrated by in vitro tests using NIH3T3-TrkC and SY5Y neuroblastoma lines as well as the NIH3T3 Met-WT non-cancerous cell line. Here, NTRK3 is linked to neuroblastoma.